av/nanobiotix--big.svg

COM:NANOBIOTIX

Nanobiotix

  • Stock

EUR

Last Close

3.50

25/11 09:24

Market Cap

237.91M

Beta: -

Volume Today

19.84K

Avg: -

Description

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal canc...Show More

peer of

competitor of